Authors: Blazar, BR McKenna, HJ Panoskaltsis-Mortari, A Taylor, PA

Citation: Br. Blazar et al., Flt3 ligand (FL) treatment of murine donors does not modify graft-versus host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality, BIOL BLOOD, 7(4), 2001, pp. 197-207

Authors: McKenna, HJ

Citation: Hj. Mckenna, Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells, CURR OPIN H, 8(3), 2001, pp. 149-154

Authors: Daro, E Pulendran, N Brasel, K Teepe, M Pettit, D Lynch, DH Vremec, D Robb, L Shortman, K McKenna, HJ Maliszewski, CR Maraskovsky, E

Citation: E. Daro et al., Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: A comparative analysis with Flt3 ligand, J IMMUNOL, 165(1), 2000, pp. 49-58

Authors: Maraskovsky, E Daro, E Roux, E Teepe, M Maliszewski, CR Hoek, J Caron, D Lebsack, ME McKenna, HJ

Citation: E. Maraskovsky et al., In vivo generation of human dendritic cell subsets by Flt3 ligand, BLOOD, 96(3), 2000, pp. 878-884

Authors: McKenna, HJ Stocking, KL Miller, RE Brasel, K De Smedt, T Maraskovsky, E Maliszewski, CR Lynch, DH Smith, J Pulendran, B Roux, ER Teepe, M Lyman, SD Peschon, JJ

Citation: Hj. Mckenna et al., Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells, BLOOD, 95(11), 2000, pp. 3489-3497

Authors: McKenna, HJ

Citation: Hj. Mckenna, Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?, CANCER IMMU, 48(6), 1999, pp. 281-286